IP Library Assignment 059493/0413
Patent Assignment
Reel/Frame 059493/0413

Assignment of Assignor's Interest

Recorded: 2022-04-04 Pages: 4
Assignor
INNOVATIVE BIOTHERAPIES, INC.
Executed: 2022-03-31
Assignee
SEASTAR MEDICAL, INC.
3513 BRIGHTON BLVD., SUITE 410, DENVER, COLORADO, 80216
Covered Properties (2)
Extracorporeal Cell-Based Therapeutic Device and Delivery System
Patent: 8,048,419 →
Application: 11/670,123 →
Publication: US 2007/0269489
Methods for Enhanced Propagation of Cells
Patent: 9,029,144 →
Application: 12/485,575 →
Publication: US 2010/0136687
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 12, 2007
From: HUMES, H. DAVID
To: INNOVATIVE BIO THERAPIES
Reel/Frame 019682/0007 →
Assignment of Assignor's Interest Oct 16, 2009
From: WESTOVER, ANGELA J.
To: NEPHRION, INC.
Reel/Frame 023384/0080 →
Assignment of Assignor's Interest Oct 16, 2009
From: WESTOVER, ANGELA J.
To: INNOVATIVE BIOTHERAPIES, INC.
Reel/Frame 023384/0113 →
Change of Name Dec 2, 2009
From: NEPHRION, INC.
To: CYTOPHERX, INC.
Reel/Frame 023592/0635 →
Confirmatory License May 13, 2010
From: INNOVATIVE BIOTHERAPIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024379/0454 →
Assignment of Assignor's Interest Jun 3, 2010
From: SZCZYPKA, MARK
To: CYTOPHERX, INC.
Reel/Frame 024478/0384 →
Confirmatory License Jul 16, 2014
From: INNOVATIVE BIOTHERAPIES, INC.
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 033338/0888 →
Asset Purchase Agreement Apr 4, 2022
From: RENAMED BIOLOGICS, INC.
To: NEPHRION, INC.
Reel/Frame 059593/0224 →
Assignment of Assignor's Interest Apr 4, 2022
From: TZIAMPAZIS, EVANGELOS
To: NEPHROS THERAPEUTICS, INC.
Reel/Frame 059492/0915 →
Change of Name Apr 4, 2022
From: NEPHRION, INC.
To: CYTOPHERX, INC.
Reel/Frame 059593/0221 →
Change of Name Apr 4, 2022
From: NEPHROS THERAPEUTICS, INC.
To: RENAMED BIOLOGICS, INC.
Reel/Frame 059593/0191 →
Change of Name Apr 4, 2022
From: CYTOPHERX, INC.
To: SEASTAR MEDICAL, INC.
Reel/Frame 059593/0257 →